The clinical significance of serum PARP-1 protein high expression in gastric cancer

Q4 Medicine

中国癌症杂志 Pub Date : 2016-02-03 DOI:10.3969/J.ISSN.1007-3969.2015.12.009

W. Rui, W. Lan, L. Mingxin

引用次数: 0

查看原文本刊更多论文

胃癌患者血清PARP-1蛋白高表达的临床意义

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

中国癌症杂志 Medicine-Oncology

CiteScore

0.50

自引率

0.00%

发文量

5398

期刊介绍： The journal of China Oncology (ISSN 1007-3639, CN 31-1727/R) started in 1991, is a peer-reviewed monthly publication, integrating scientific information from global sources for all oncologic specialties. It is an open access monthly published journal in Chinese and English. The competent authorities of China Oncology is the Ministry of Education of the People’s Republic of China. China Oncology is hosted by one of the most prestigious comprehensive cancer centers, the Fudan University Shanghai Cancer Center. Database Index At present, China Oncology is indexed in the following most powerful database: SCOPUS, DOAJ, Chemical Abstracts (CAS), EMBASE, EBSCO, Japan Science and Technology Database (JST), Index of Copernicus International (ICI) and Western Pacific Region Index Medicus (WPRIM), Ulrich's Periodical Directory, Chinese Science Citation Database (CSCD), A Guide to the Core Journal of China, Chinese Scientific and Technical Papers and Citations Database (CSTPCD), Chinese Academic Journal Comprehensive Evaluation Database (CAJCED), Chinese Medical Current Content (CMCC), Chinese Medical Citation Index (CMCI),Chinese Biological Abstracts (CBA), GoOA,COAJ, Level A of Fudan University degree and Graduate Education Domestic Journals Guideline, Research Center for Chinese Science Evaluation (RCCSE), World Journal Clout Index (WJCI) Report of Scientific and Technological Periodicals (2023). Besides, China Oncology continuously acquired Certificate of Outstanding S&T Journals of China (F5000) since 2017.